Contrast ultrasound dispersion imaging (CUDI) as a diagnostic modality in the diagnosis of renal cell carcinoma.

Completed

• Conditions: kidney cancer; renal cell carcinoma; 10038364; 10038430

• Registration Number: NL-OMON49171
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

· age * 18 years
· signed informed consent
· scheduled for a radical- or partial nephrectomy for the suspicious of a renal
tumor.

Exclusion Criteria

· Earlier treatment of renal masses
· History of any clinically evidence of cardiac right-to-left shunts
· Severe pulmonary hypertension (pulmonary artery pressure >90 mmHg) or
uncontrolled systemic hypertension or respiratory distress syndrome
· Has any medical condition or other circumstances which would significantly
decrease the chances of obtaining reliable data, achieving study objectives, or
completing the study
· Is incapable of understanding the language in which the information for the
patient is given
· Tumor cannot be visualized/localized on ultrasound imaging

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Parameters defined by CUDI-quantification that correlate with the pathology<br /><br>results.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Nvt</p><br>